Rapport d’analyse de la taille, de la part et des tendances du marché mondial de la spectroscopie moléculaire – Aperçu et prévisions de l’industrie jusqu’en 2031

Analyse du marché de la spectroscopie moléculaire

Le marché de la spectroscopie moléculaire connaît une croissance rapide, en raison des améliorations techniques rapides et de la demande accrue dans des secteurs tels que les produits pharmaceutiques , les soins de santé et les tests environnementaux. La croissance du marché est tirée par des avancées telles que les techniques améliorées de spectroscopie proche infrarouge (NIR) et Raman, qui ont transformé la précision et les capacités analytiques. Ces avancées permettent une analyse moléculaire plus précise et plus efficace, facilitant un large éventail d'applications, du développement de médicaments et du contrôle qualité dans l'industrie pharmaceutique aux outils de diagnostic sophistiqués dans les soins de santé.

Taille du marché de la spectroscopie moléculaire

Français La taille du marché mondial de la spectroscopie moléculaire était évaluée à 7,74 millions USD en 2023 et devrait atteindre 13,61 millions USD d'ici 2031, avec un TCAC de 7,3 % au cours de la période de prévision de 2024 à 2031. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Tendances du marché de la spectroscopie moléculaire

« Une attention accrue portée à l’amélioration des normes environnementales »

L’accent mis à l’échelle mondiale sur l’amélioration des normes environnementales, ainsi que la demande de procédures de test précises et fiables, stimulent la croissance du marché de la spectroscopie moléculaire. La spectroscopie moléculaire, en particulier la spectroscopie Raman et proche infrarouge (NIR), joue un rôle crucial pour identifier et mesurer les contaminants dans l’air, l’eau et le sol. Par exemple, la spectroscopie Raman est largement utilisée pour identifier les contaminants chimiques et surveiller la qualité de l’eau en temps réel, fournissant des données importantes pour la conformité environnementale. Alors que les acteurs de tous les secteurs recherchent des solutions analytiques avancées pour répondre aux exigences réglementaires et gérer les préoccupations environnementales, le marché de la spectroscopie moléculaire se développe encore davantage.

Portée du rapport et segmentation du marché de la spectroscopie moléculaire     

Molecular Spectroscopy Market Definition

Molecular spectroscopy is a branch of spectroscopy that involves the study of the interaction between electromagnetic radiation and molecules. It focuses on how molecules absorb, emit, or scatter light at different wavelengths, providing detailed information about their structure, composition, and behaviour. By analysing these interactions, molecular spectroscopy helps in identifying molecular properties, characterizing substances, and understanding various chemical processes.

Molecular Spectroscopy Market Dynamics

Drivers

• Increasing Demand Of Molecular Spectroscopy In Pharmaceuticals

The pharmaceutical industry relies heavily on molecular spectroscopy for drug development, quality control, and regulatory compliance. For instance, Raman spectroscopy is used to analyze the molecular composition of drug formulations, ensuring the correct drug compound and verifying its stability over time. This technique helps identify and quantify active pharmaceutical ingredients (APIs) and excipients, ensuring that formulations meet strict regulatory standards and maintain consistent quality. Such demand for rigorous analytical methods in drug development and manufacturing propels the growth of the molecular spectroscopy market.

• Rising Use in the Biotechnology Industry

The increasing utilization of molecular spectroscopy in the biotechnology industries is significantly boosting the market's growth rate. For instance, the Thermo Fisher Scientific Q Exactive HF-X Mass Spectrometer is widely used in pharmaceutical research for its high-resolution capabilities, enabling precise identification of complex drug molecules and metabolites. In biotechnology, molecular spectroscopy aids in the characterization of biomolecules and the optimization of bioprocesses. Such growing reliance on advanced spectroscopic techniques reflects a broader trend towards more sophisticated analytical methods, driving substantial growth in the molecular spectroscopy market.

Opportunities

• Research and Development Investments

Increased investments in R&D across sectors such as materials science, nanotechnology, and chemical engineering are significantly fueling the demand for advanced spectroscopy tools, presenting a substantial opportunity for the molecular spectroscopy market. For instance, Wipro GE Healthcare has announced a USD 960 million investment in its manufacturing and R&D facilities in India, underscoring the growing emphasis on developing sophisticated analytical technologies. This investment reflects a broader trend where major players are channelling substantial resources into enhancing their capabilities, driving advancements in molecular spectroscopy.

• Advancements in Spectroscopy Technology

Innovations such as the integration of machine learning algorithms with molecular spectroscopy are transforming data analysis and interpretation, leading to significant advancements in the field. By applying machine learning techniques to spectral data, researchers can achieve more precise and automated analysis, reducing the time and complexity traditionally associated with data interpretation. For instance, machine learning algorithms can identify subtle spectral patterns and correlations that might be missed by manual analysis, enhancing the accuracy of Fourier-transform infrared (FTIR) and Raman spectroscopy. Such synergy streamlines the process and also increases the efficiency and value of these techniques across diverse applications, such as material science and pharmaceuticals. As a result, the combination of machine learning with molecular spectroscopy represents a transformative opportunity for advancing research and development across multiple industries.

Restraints/Challenges

• Stringent regulations

In Japan, the Pharmaceuticals and Medical Devices Agency (PMDA) imposes stringent regulations on molecular spectroscopy equipment used in pharmaceutical applications, such as those outlined in the Pharmaceutical Affairs Law (PAL) and the Good Manufacturing Practice (GMP) guidelines. Compliance with PMDA guidelines requires extensive validation procedures, detailed documentation, and adherence to specific quality standards for molecular spectroscopy. For instance, spectroscopy devices must undergo rigorous testing to ensure they meet the accuracy and reliability standards set forth by the PMDA. Such regulations mandate thorough performance validation, including detailed calibration and verification processes, which can lead to substantial additional costs and administrative efforts for manufacturers.

• High Cost Of Spectroscopy Instruments

The initial investment required for advanced systems, such as high-resolution FTIR or NMR spectrometers, can be prohibitively expensive. These sophisticated instruments, essential for precise and reliable molecular analysis, often come with high costs that may restrict spectroscopy instruments accessibility, particularly for smaller laboratories, research institutions, and organizations with constrained budgets. Such financial barriers can slow down the adoption of cutting-edge spectroscopy technologies and hinder their integration into broader research and industrial applications. Consequently, the high cost of equipment can restrict market growth by narrowing the pool of potential users and slowing the advancement of new technologies.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Molecular Spectroscopy Market Scope

The market is segmented on the basis of technology, and application. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

• Nuclear Magnetic Resonance Spectroscopy
• UV-Visible Spectroscopy
• Infrared Spectroscopy
  • Mid-Wave Infrared Spectroscopy
  • Short-Wave Infrared Spectroscopy
  • Far-Wave Infrared Spectroscopy
  • Benchtop
  • Infrared Microscopy
  • Portable & Handheld
  • Hyphenated
  • Terahertz
• Near-Infrared Spectroscopy
  • Scanning Near-Infrared Spectroscopy
  • Fourier-Transform Near-Infrared Spectroscopy
  • Filter-Nir Spectroscopy/Acoustic-Optical Tunable Filter-Nir Spectroscopy
• Colour Measurement Spectroscopy
• Raman Spectroscopy
  • Surface-Enhanced Raman Scattering
  • Tip-Enhanced Raman Scattering
  • Micro-Raman Spectroscopy
  • Probe-Based Raman Spectroscopy
  • Ft-Raman Spectroscopy
• Other Technologies

Application

• Pharmaceutical Applications
• Food and Beverage Testing
• Biotechnology and Biopharmaceutical Applications
• Environmental Testing
• Academic Research
• Other Applications

Molecular Spectroscopy Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, technology, and application.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the global molecular spectroscopy market due to its robust healthcare infrastructure, the significant presence of key industry players, and a large patient population seeking advanced cancer diagnostics. The regions strong base of healthcare facilities further supports its dominance, while ongoing investments in research and development drive continued innovation and growth.

Asia-Pacific is projected to experience substantial growth from 2024 to 2031, driven by increased government initiatives to enhance healthcare, heightened health awareness among the population, and a rising demand for advanced medical technology. The region's large population and growing need for high-quality healthcare further contribute to this expected growth.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Molecular Spectroscopy Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Molecular Spectroscopy Market Leaders Operating in the Market Are:

• Thermo Fisher Scientific Inc. (U.S.)
• Bruker (U.S.)
• PerkinElmer (U.S.)
• Agilent Technologies, Inc. (U.S.)
• Eurofins Scientific (Luxembourg)
• Danaher Corporation (U.S.)
• Merck KGaA (Germany)
• Siemens Medical Solutions USA, Inc.
• Medtronic (Ireland)
• ABB (Switzerland)
• B&W Tek. (U.S.)
• ROBERT BOSCH TOOL CORPORATION (U.S.)
• Hamamatsu Photonics K.K. (Japan)
• HORIBA, Ltd. (Japan)
• JASCO INTERNATIONAL CO., LTD.(Japan)
• JEOL Ltd. (Japan)
• Endress+Hauser Group Services AG (Switzerland)
• Metrohm AG  (Switzerland)
• Montana Instruments Corporation. (U.S.)
• Teledyne Technologies (U.S.)
• Renishaw plc. (U.K.)
• Shimadzu Corporation (Japan)

Latest Developments in Molecular Spectroscopy Market

• In April 2023, Edinburgh Instruments unveiled its latest innovation, the IR5 benchtop FTIR Spectrometer, developed and produced at their global headquarters in Scotland. This marks the debut of the Edinburgh Instruments brand in the realm of Fourier Transform Infrared (FTIR) spectroscopy, complementing their established expertise in Raman, fluorescence, and UV-Vis absorption spectroscopies. The IR5 is a cutting-edge, high-performance FTIR instrument that offers the flexibility of being equipped with either a second detector or Fourier Transform Photoluminescence (FT-PL) capability, making it a versatile addition to their product lineup.
• En mars 2024, LGM Pharma, un important fournisseur de services API et CDMO personnalisés tout au long du cycle de vie des produits pharmaceutiques, a annoncé une amélioration majeure de ses capacités. La société élargit son offre de services de tests analytiques (ATS) de 50 % et investit plus de 2 millions USD dans ce service autonome. En outre, LGM Pharma introduit de nouvelles capacités de fabrication de suppositoires dans son portefeuille de développement et de fabrication sous contrat (CDMO).

SKU-1744